Cargando…

An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy

Monoclonal antibodies targeting the programmed cell death protein 1 (PD-1) remain the most prevalent cancer immunotherapy both as a monotherapy and in combination with additional therapies. Despite the extensive success of anti-PD-1 monoclonal antibodies in the clinic, the experimental relationship...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cowles, Sarah C., Sheen, Allison, Santollani, Luciano, Lutz, Emi A., Lax, Brianna M., Palmeri, Joseph R., Freeman, Gordon J., Wittrup, K. Dane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354768/ https://www.ncbi.nlm.nih.gov/pubmed/35924382 http://dx.doi.org/10.1080/19420862.2022.2088454

Ejemplares similares

Tregs constrain CD8(+) T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy
por: Palmeri, Joseph R., et al.
Publicado: (2023)

Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
por: Lutz, Emi A., et al.
Publicado: (2022)

Tumor-localized catalases can fail to alter tumor growth and transcriptional profiles in subcutaneous syngeneic mouse tumor models
por: Sheen, Allison, et al.
Publicado: (2023)

Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
por: Agarwal, Yash, et al.
Publicado: (2022)

Maximizing response to intratumoral immunotherapy in mice by tuning local retention
por: Momin, Noor, et al.
Publicado: (2022)

Intratumoral nanobody–IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in mice
por: Lutz, Emi A, et al.
Publicado: (2022)

Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2
por: Horton, Brendan L., et al.
Publicado: (2023)

A constant affinity threshold for T cell tolerance
por: Naeher, Dieter, et al.
Publicado: (2007)

Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies
por: Wang, Shenshen, et al.
Publicado: (2015)

Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
por: Kang, Byong H., et al.
Publicado: (2021)

Yeast surface display for protein engineering and characterization
por: Gai, S Annie, et al.
Publicado: (2007)

Cytosolic delivery of siRNA by ultra-high affinity dsRNA binding proteins
por: Yang, Nicole J., et al.
Publicado: (2017)

Maximum a posteriori Threshold Genomic Prediction Model for Ordinal Traits
por: Montesinos-López, Abelardo, et al.
Publicado: (2020)

Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
por: Gao, Yang, et al.
Publicado: (2020)

Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival
por: Opel, Cary F, et al.
Publicado: (2013)

Maximum-Entropy Models of Sequenced Immune Repertoires Predict Antigen-Antibody Affinity
por: Asti, Lorenzo, et al.
Publicado: (2016)

Comparison of Different Minimal Velocity Thresholds to Establish Deadlift One Repetition Maximum
por: Lake, Jason, et al.
Publicado: (2017)

Assessment of Pain Onset and Maximum Bearable Pain Thresholds in Physical Contact Situations
por: Han, Doyeon, et al.
Publicado: (2022)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
por: Hughes, Jing, et al.
Publicado: (2015)

Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
por: Mitchell, Dana, et al.
Publicado: (2019)

Inequality of maximum a posteriori estimators with equivalent sire and animal models for threshold traits
por: Mayer, M
Publicado: (1995)

High‐affinity PD‐1 molecules deliver improved interaction with PD‐L1 and PD‐L2
por: Li, Yanyan, et al.
Publicado: (2018)

The dependence of maximum oxygen uptake and utilization (V̇O(2)max) on hemoglobin‐oxygen affinity and altitude
por: Webb, Kevin L., et al.
Publicado: (2023)

A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA
por: Liu, David V, et al.
Publicado: (2014)

Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy
por: García-Aranda, Marilina, et al.
Publicado: (2019)

Systemic Anti–PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
por: Portnow, Jana, et al.
Publicado: (2020)

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
por: Bevins, Nicholas J., et al.
Publicado: (2022)

Influence of Compression Thresholds and Maximum Power Output on Speech Understanding with Bone-Anchored Hearing Systems
por: Gawliczek, Tom, et al.
Publicado: (2021)

Supra-threshold vibration applied to the foot soles enhances jump height under maximum effort
por: Moon, Jeongin, et al.
Publicado: (2022)

The Free Lunch is not over yet—systematic exploration of numerical thresholds in maximum likelihood phylogenetic inference
por: Haag, Julia, et al.
Publicado: (2023)

Magneto-nanosensor platform for probing low-affinity protein–protein interactions and identification of a low-affinity PD-L1/PD-L2 interaction
por: Lee, Jung-Rok, et al.
Publicado: (2016)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

Synergistic Antitumor Activity from Two-Stage Delivery of Targeted Toxins and Endosome-Disrupting Nanoparticles
por: Su, Xingfang, et al.
Publicado: (2013)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

Connecting the sequence dots: shedding light on the genesis of antibodies reported to be designed in silico
por: Vásquez, Maximiliano, et al.
Publicado: (2019)

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
por: Zhang, Hao, et al.
Publicado: (2023)

DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity
por: Kureshi, Rakeeb, et al.
Publicado: (2023)

Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique
por: Veldwijk, Jorien, et al.
Publicado: (2023)

Relationship of maximum walking speed with peak oxygen uptake and anaerobic threshold in male patients with heart failure
por: Koen, Masahiro, et al.
Publicado: (2023)

Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy
por: Cefalì, Marco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m89ln98qu9jm3glcrc86hdesje